Madelon Dijkstra
Papers
1
Total Citations
47
H-Index
1
About
Madelon Dijkstra is a leading clinical researcher in surgical oncology, with a primary focus on the treatment of colorectal liver metastases (CRLM). Her most impactful work centers on comparing surgical resection and thermal ablation, aiming to redefine standard-of-care practices for patients with small-size liver tumors. As a key contributor to the landmark COLLISION trial—an international, multicenter, phase III randomized controlled trial—Dijkstra has provided pivotal evidence that thermal ablation offers a superior safety profile, lower costs, and shorter hospital stays while achieving comparable oncologic outcomes to surgery. This work, published in 2024 and already cited 47 times, has rapidly influenced clinical decision-making and sparked further investigation into minimally invasive alternatives. Her research addresses a critical gap in hepatobiliary oncology, challenging long-held surgical paradigms. Dijkstra’s contributions are particularly notable for their direct impact on patient quality of life and healthcare resource utilization. Through rigorous trial design and collaborative international efforts, she has established herself as a rising authority in interventional oncology, with her findings poised to shape future guidelines for managing colorectal liver metastases.
Research Focus
Key Achievements
Top Papers
- 1